Author Correction: A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma
Open Access
- 8 March 2022
- journal article
- correction
- Published by Springer Nature in Nature Medicine
- Vol. 28 (4) , 871